Potentially largest ever Japan outbound deal

25 April 2018. Published by Nigel Collins, Partner, Head of Japan Desk

Takeda makes its 5th offer for Shire

Takeda is showing how determined it is to acquire Shire, the London-listed pharmaceutical focused on treatments for rare diseases and attention deficit disorder. Impressive that it's now made what is likely to be a winning £46 billion offer. The other suitor who sat in the wings disturbing the party for a while, Allergen Plc, have ruled themselves out of making an offer last week. Brexit is less of an issue when you have a global strategy; it's about acquiring the right target wherever it is based. For more detail see: Japan Times Article

Stay connected and subscribe to our latest insights and views 

Subscribe Here